Filing Flows › Korsana Biosciences (KRSA) › R&D spending
Korsana Biosciences (KRSA) R&D spending by quarter
Korsana Biosciences' R&D spending was $519K in Q4 2025 (fourth quarter 2025), +49% from Q3 2025. Over the last 5 quarters it ranged from $36K (Q1 2025) to $519K (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q4 2025 | $519K | +49% | +827% |
| Q3 2025 | $348K | +521% | — |
| Q2 2025 | $56K | +56% | — |
| Q1 2025 | $36K | -36% | — |
| Q4 2024 | $56K | — | — |
Q4 2025 at a glance
Korsana Biosciences, Q4 2025: revenue $1.0M (-43% year over year), operating margin -81.8%, net loss $799K, operating cash flow −$1.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Korsana Biosciences' R&D spending?
Korsana Biosciences' R&D spending was $519K in Q4 2025 (fourth quarter 2025), +49% from Q3 2025.
How has Korsana Biosciences' R&D spending changed?
Over the last 5 quarters it ranged from $36K (Q1 2025) to $519K (Q4 2025).